Table 1.

Demographics of 1,402 BMT Patients Receiving Transplants at Johns Hopkins Hospital from January 1, 1986 to June 30, 1995

No. of Patients %
Diagnosis  
 AA  20  1.4 
 AML  289 (140, 149)  20.6  
 ALL 124 (51, 73)  8.8  
 Breast cancer  199  14.2 
 CML  181 (148, 33)  12.9  
 HD 112 (62, 48)  8.0  
 NHL  279 (216, 59) 19.9  
 MM  32  2.3  
 Others  166  11.8  
Type of BMT  
 Autologous  887  63.3  
 Allogeneic  469 33.5  
 Unrelated  24  1.7  
 Others  22  1.5 
Preparative regimen  
 Bu-Cy  520  37.1  
 Bu-VP-Cy 122  8.7  
 Cy-CSA  19  1.4  
 Cy-TBI  410 29.2  
 Cy-Thio  199  14.2  
 VP-CBDCA-Cy  90 6.4  
 Others  42  3.0  
Age  
 Pediatric  294 21.0  
 Adults  1,108  79.0  
Sex  
 Females  676 48.2  
 Males  726  51.8 
No. of Patients %
Diagnosis  
 AA  20  1.4 
 AML  289 (140, 149)  20.6  
 ALL 124 (51, 73)  8.8  
 Breast cancer  199  14.2 
 CML  181 (148, 33)  12.9  
 HD 112 (62, 48)  8.0  
 NHL  279 (216, 59) 19.9  
 MM  32  2.3  
 Others  166  11.8  
Type of BMT  
 Autologous  887  63.3  
 Allogeneic  469 33.5  
 Unrelated  24  1.7  
 Others  22  1.5 
Preparative regimen  
 Bu-Cy  520  37.1  
 Bu-VP-Cy 122  8.7  
 Cy-CSA  19  1.4  
 Cy-TBI  410 29.2  
 Cy-Thio  199  14.2  
 VP-CBDCA-Cy  90 6.4  
 Others  42  3.0  
Age  
 Pediatric  294 21.0  
 Adults  1,108  79.0  
Sex  
 Females  676 48.2  
 Males  726  51.8 

In parenthesis (after the number of patients) are numbered the good- and poor-risk patients for each diagnosis.